BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16485108)

  • 21. Enhanced COMP catabolism detected in serum of patients with arthritis and animal disease models through a novel capture ELISA.
    Lai Y; Yu XP; Zhang Y; Tian Q; Song H; Mucignat MT; Perris R; Samuels J; Krasnokutsky S; Attur M; Greenberg JD; Abramson SB; Di Cesare PE; Liu CJ
    Osteoarthritis Cartilage; 2012 Aug; 20(8):854-62. PubMed ID: 22595227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of reduced serum cartilage oligomeric matrix protein levels in systemic juvenile idiopathic arthritis patients treated with the anti-interleukin-6 receptor monoclonal antibody tocilizumab.
    Nakajima S; Naruto T; Miyamae T; Imagawa T; Mori M; Nishimaki S; Yokota S
    Mod Rheumatol; 2009; 19(1):42-6. PubMed ID: 18726067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and its correlation with sonographic knee cartilage thickness and disease activity.
    Sakthiswary R; Rajalingam S; Hussein H; Sridharan R; Asrul AW
    Clin Rheumatol; 2017 Dec; 36(12):2683-2688. PubMed ID: 28889184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cartilage Oligomeric Matrix Protein (COMP) in systemic sclerosis (SSc): role in disease severity and subclinical rheumatoid arthritis overlap.
    Gheita TA; Hussein H
    Joint Bone Spine; 2012 Jan; 79(1):51-6. PubMed ID: 21497537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of serum cartilage oligomeric matrix protein as a prognostic marker of large-joint damage in rheumatoid arthritis--data from the RAPIT study.
    de Jong Z; Munneke M; Vilim V; Zwinderman AH; Kroon HM; Ronday HK; Lems WF; Dijkmans BA; Breedveld FC; Vliet Vlieland TP; Hazes JM; Degroot J
    Rheumatology (Oxford); 2008 Jun; 47(6):868-71. PubMed ID: 18400837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can tocilizumab decrease cartilage oligomeric matrix protein levels and disease activity in patients with long-standing rheumatoid arthritis?
    Benucci M; Meacci F; Manfredi M; Gobbi FL; Infantino M; Ricci C; Sarzi-Puttini P; Atzeni F
    Curr Rheumatol Rev; 2014; 10(2):131-5. PubMed ID: 25599685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion.
    Fujikawa K; Kawakami A; Tamai M; Uetani M; Takao S; Arima K; Iwamoto N; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Aoyagi K; Eguchi K
    J Rheumatol; 2009 Jun; 36(6):1126-9. PubMed ID: 19447929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High specificity but low sensitivity of the cartilage oligomeric matrix protein (COMP) test in rheumatoid arthritis and osteoarthritis.
    Bender AL; da Silveira IG; von Mühlen CA; Staub HL
    Clin Chem Lab Med; 2010 Apr; 48(4):569-70. PubMed ID: 20148721
    [No Abstract]   [Full Text] [Related]  

  • 29. Increased serum concentrations of cartilage oligomeric matrix protein. A prognostic marker in early rheumatoid arthritis.
    Forslind K; Eberhardt K; Jonsson A; Saxne T
    Br J Rheumatol; 1992 Sep; 31(9):593-8. PubMed ID: 1525624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritis.
    Andersson ML; Petersson IF; Karlsson KE; Jonsson EN; Månsson B; Heinegård D; Saxne T
    Ann Rheum Dis; 2006 Nov; 65(11):1490-4. PubMed ID: 16707535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes of cartilage and bone markers after intra-articular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritis.
    Weitoft T; Larsson A; Saxne T; Rönnblom L
    Ann Rheum Dis; 2005 Dec; 64(12):1750-3. PubMed ID: 15843449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers.
    Young-Min S; Cawston T; Marshall N; Coady D; Christgau S; Saxne T; Robins S; Griffiths I
    Arthritis Rheum; 2007 Oct; 56(10):3236-47. PubMed ID: 17907159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of cartilage oligomeric matrix protein (COMP) and a COMP neoepitope in synovial fluid of patients with different joint disorders by novel automated assays.
    Lorenzo P; Aspberg A; Saxne T; Önnerfjord P
    Osteoarthritis Cartilage; 2017 Sep; 25(9):1436-1442. PubMed ID: 28473207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies against cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early arthritis: relation to diagnosis and disease activity.
    Söderlin MK; Kastbom A; Kautiainen H; Leirisalo-Repo M; Strandberg G; Skogh T
    Scand J Rheumatol; 2004; 33(3):185-8. PubMed ID: 15228190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term infliximab therapy improves symptoms of psoriatic arthritis and decreases concentrations of cartilage oligomeric matrix protein.
    Cauza E; Hanusch-Enserer U; Frischmuth K; Fabian B; Dunky A; Kostner K
    J Clin Pharm Ther; 2006 Apr; 31(2):149-52. PubMed ID: 16635048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA DRB1* typing and cartilage oligomeric matrix protein (COMP) as predictors of joint destruction in recent-onset rheumatoid arthritis.
    Wollheim FA; Eberhardt KB; Johnson U; Saxne T
    Br J Rheumatol; 1997 Aug; 36(8):847-9. PubMed ID: 9291852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Serum cartilage oligomeric matrix protein (COMP) in the diagnosis of rheumatoid arthritis (RA): A case-control study.
    Liu F; Wang X; Zhang X; Ren C; Xin J
    J Int Med Res; 2016 Aug; 44(4):940-9. PubMed ID: 27217240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased serum levels of cartilage oligomeric matrix protein in patients with psoriasis vulgaris: a marker for unknown peripheral joint involvement?
    Skoumal M; Haberhauer G; Fink A; Steiner A; Klingler A; Varga F; Klaushofer K
    Clin Exp Rheumatol; 2008; 26(6):1087-90. PubMed ID: 19210875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum cartilage oligomeric matrix protein (COMP) levels in knee osteoarthritis in a Brazilian population: clinical and radiological correlation.
    Fernandes FA; Pucinelli ML; da Silva NP; Feldman D
    Scand J Rheumatol; 2007; 36(3):211-5. PubMed ID: 17657676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis.
    Vilím V; Vytásek R; Olejárová M; Machácek S; Gatterová J; Procházka B; Kraus VB; Pavelka K
    Osteoarthritis Cartilage; 2001 Oct; 9(7):612-8. PubMed ID: 11597173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.